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Increased release of insulin is usually regarded as a symptom of metabolic syndrome, 
contributing to insulin resistance in peripheral organs thus affecting glucose and insulin 
homeostasis. The existing animal models to address the metabolic syndrome are currently not 
optimal. In neuronal, neuroendocrine and endocrine cells, stimulus-dependent membrane 
fusion occurs via the SNARE complex, formed by the membrane-associated proteins SNAP-
25 and syntaxin and the vesicle-associated protein VAMP-2, and requires intracellular Ca2+ 
elevations. The SNAP-25 protein exists as two splicing variants, SNAP-25a and SNAP-25b, 
differing in only 9 out of 206 amino acids. Both isoforms can mediate membrane fusion but 
their specific functions still remain unknown.   
In this thesis, we have investigated if an apparently small modification in the exocytotic 
machinery could act as triggering factor for development of metabolic syndrome. We used a 
genetically modified mouse expressing normal levels of SNAP-25, but with only the SNAP-
25a isoform available. In Paper I, by monitoring a number of metabolic parameters during 7 
weeks on control or Western (high fat/high sucrose) diet, we found that SNAP-25b-
deficiency leads to metabolic syndrome, characterised by hyperinsulinemia, obesity, 
hyperglycaemia, liver steatosis and adipocyte hypertrophy. These conditions were even more 
pronounced when the mutation was combined with Western diet. The metabolic phenotype 
caused by SNAP-25b-deficiency was accompanied by increased insulin secretion from the 
islets of Langerhans partially involving beta cell hyperplasia in a sex dependent manner. In 
Paper II we addressed these issues closer and focused on islet physiology by monitoring 
intracellular Ca2+ dynamics in beta cells upon glucose stimulation. SNAP-25b-deficiency 
impaired the collective control of Ca2+ oscillations in beta cells with early initiation and 
delayed termination of activity as well as decreased synchronicity. Derangements of 
intracellular Ca2+ oscillatory patterns can be related to the increased insulin secretion found in 
SNAP-25b-deficient mice. In Paper III we observed that the SNAP-25 isoforms mediate 
different interactions with proteins important for the strict control of exocytosis both in 
neurons and beta cells, such as Munc18-1 and the Gβγ subunits of the heterotrimeric G 
proteins. 
In summary, we have shown that even a small modification in the machinery regulating 
membrane fusion, such as replacing SNAP-25b with SNAP-25a, acts as a triggering factor 
for the development of metabolic syndrome in mice. This condition was associated with loss 
of preciseness of Ca2+ oscillations in beta cells and increased insulin secretion. Thus, we 
propose the SNAP-25b-deficient mouse as a new model of metabolic syndrome and 
prediabetes.  
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1 INTRODUCTION 
1.1 METABOLIC SYNDROME 
1.1.1 What is the metabolic syndrome? 
The metabolic syndrome is a cluster of several metabolic abnormalities, such as 
hyperinsulinemia, central obesity, insulin resistance, elevated blood pressure, impaired 
fasting glucose and/or glucose tolerance and dyslipidaemia 1. All these risk factors appear to 
be influenced by both genetic background and environmental influences. Individuals with 
metabolic syndrome have a five-fold increased risk of developing type 2 diabetes (T2D) 2.  
1.1.2 Tissues affected by metabolic syndrome 
During development of the metabolic syndrome, many tissues are affected, mainly the brain, 
liver, pancreas, adipose tissue and muscle.  
An improper metabolic control can originate from impaired brain sensing of energy balance 
and integration of feedback signals from the periphery. Neuronal nuclei involved in the 
sensation of adiposity, satiety and glucose are highly concentrated in the hypothalamus, 
which is currently an important area of investigation 3. Progressing hyperinsulinemia and 
hyperleptinemia result in an impaired sensation or transduction in hypothalamic neurons 
(insulin/leptin resistance), ultimately leading to increased food intake. Alterations in neuronal 
intracellular metabolism, such as mitochondrial dysfunctions and endoplasmic reticulum 
(ER) stress, also contribute to the metabolic disease state 4. 
The altered secretion of adipokines during the metabolic syndrome causes ectopic lipid 
deposition in the liver. This excessive storage causes an intracellular pro-inflammatory state, 
giving rise to a variety of liver pathologies from mild hepatosteatosis (or fatty liver disease) 
to non-alcoholic steatohepatitis. Hepatic insulin resistance affects intracellular signalling 
pathways, leading to increased hepatic glucose production, a hallmark of T2D 5.  
Insulin resistance leads to compensatory increases in insulin release from beta cells within 
the islets of Langerhans. Chronic hyper production of insulin in beta cells causes beta cell 
expansion (or “islet hypertrophy”), resulting in enlarged islets in the pancreas 6. When insulin 
resistance progresses, the effects of insulin in target tissues diminishes and beta cells 
progressively fail to release sufficient amount of insulin. T2D is characterised by a complete 
loss of the first phase of insulin secretion and diminished second phase (described in 1.3.3) 
7,8.  
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In the presence of excessive caloric intake, the adipose tissue expands as a result of 
adipocyte hypertrophy and hyperplasia. The adipocytes challenged by metabolic syndrome 
are characterised by high degree of inflammation and insulin resistance which turns out to 
stimulate lipolysis and increase the storage of lipids in non-adipose tissues. The release of 
adipokines is compromised, with elevated leptin levels and diminished adiponectin levels 9,10. 
Insulin resistance in skeletal muscle is an important factor in the pathogenesis of T2D. It can 
be mostly attributed to defects in insulin signalling and glucose transport which results in 
decreased glycogen synthesis. Possible causes of this phenomenon include ectopic lipid 
accumulation in myocytes, changed release of adipokines associated with inflammation and 
intracellular accumulation of reactive oxygen species (ROS) 11,12. 
1.1.3 Mouse models vs humans 
The metabolic syndrome is dramatically increasing worldwide and the International Diabetes 
Federation (IDF) has estimated that 20-25% of the population is affected by the disease. It is 
therefore crucial to experimentally study causes and progression of metabolic impairments. A 
major issue when studying mouse models is that none can mimic all the aspects of the human 
metabolic syndrome. Most of the models used for the study of obesity arose from 
spontaneous mutations in the leptin or leptin receptor gene (Lepob/ob and LepRdb/db mice) and 
although they develop a metabolic phenotype close to the human syndrome (obesity, insulin 
resistance, glucose intolerance and hepatic steatosis), similar mutations in humans are very 
rare 13.  
So far, the best model to resemble the human metabolic syndrome and for testing potential 
therapeutic interventions is chronic consumption of a high fat/high sucrose diet.  
1.2 REGULATED EXOCYTOSIS  
1.2.1 The process of exocytosis 
Exocytosis is the cellular process by which certain substances packed into vesicles can be 
released outside the cell by fusion with the plasma membrane. It requires the interplay of 
different proteins and mechanisms depending on the cellular type but overall the process is 
highly conserved in eukaryotic cells 14. Exocytosis exists as constitutive and regulated and 
they both require expenditure of energy. Constitutive exocytosis is a continuous, rather slow, 
process performed by all cells for delivering newly synthetised (membrane) proteins to be 
incorporated in the plasma membrane or components released to build the extracellular 
matrix. Regulated exocytosis is modulated by secretagogues and allows a rapid and massive 
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release after physiologically appropriate stimuli and is preceded by influx of extracellular 
Ca2+. It occurs only in specialised secretory cells such as neurons, endocrine and 
neuroendocrine cells 15. In neurons regulated exocytosis is achieved through two types of 
vesicles: small synaptic vesicles (SVs), usually at the nerve terminal containing acetylcholine, 
catecholamine and glutamate and large dense-core vesicles (LDCVs), transporting condensed 
proteins and peptides. In endocrine and neuroendocrine cells, fast exocytosis is achieved by 
synaptic-like microvesicles (SLMVs), larger than SVs, whereas slow exocytosis occurs 
through secretory granules (SGs) (endocrine cells) and LDCVs (neuroendocrine cells) 16,17. 
SVs are smaller (diameter < 30nm) compared to LDCVs (hundreds of nm) and mediate 
exocytosis at least one order of magnitude faster than LDCVs, requiring higher intracellular 
Ca2+ concentrations, [Ca2+]i 18–20.  
The vesicles can be classified into different pools, depending on their release capability and 
kinetics of fusion 21,22. There are two releasable pools of vesicles: the first one comprises the 
fast burst component and belongs to the ready releasable pool (RRP), the slow burst 
component is built by the fusion of the slowly releasable pool (SRP). The releasable pools are 
refilled from the unprimed pool (UPP) during “priming” (see below) and account for the 
sustained component of exocytosis. At last, the depot pool (DP) represents the largest pool in 
adrenal chromaffin cells where the vesicles are used to refill the UPP upon depletion during 
“docking” step (see below) 22. 
During regulated membrane fusion, the vesicles undergo a number of biochemical steps that 
will eventually lead to fusion with the plasma membrane. These stages are classified into 
docking, priming and fusion (Figure 1). The docking corresponds to the transfer of vesicles 
from the DP to the UPP and their allocation in proximity of the plasma membrane (or active 
zone for SVs). During the priming process, UPP are transferred to a releasable pool (RP) 
stage with the formation of the trimeric SNARE complex 23,24. Finally the fusion process 
occurs when the vesicle either collapses with the plasma membrane (“full collapse” fusion) or 
a small fusion pore opens for releasing part of the vesicle content and then closes (“kiss-and-
run” fusion) 22,25. 
Membrane fusion is achieved with a concomitant entry of Ca2+ via the opening of voltage-
dependent Ca2+ channels (VDCCs). The raise in [Ca2+]i initiates signal transduction with short 
and long term effects on secretion, for example by activating protein kinases or by inducing 
direct interactions between exocytic proteins located in the vesicle membrane and those 
situated in the plasma membrane 26–29.  
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Figure 1. Schematic mechanisms of regulated membrane fusion. During docking the vesicle/granule approaches 
the plasma membrane and during priming the assembly of the SNARE complex occurs. Membrane fusion is 
triggered when Ca2+ enters the cell via VDCCs. 
 
1.2.2 The SNARE complex 
A vesicle fusion event requires many coordinated and regulated steps. Rothman, Schekman 
and Südhof have been pioneers for the discovery of proteins necessary for this process 24,30,31. 
The SNARE complex acts as a conserved core protein machinery for all membrane fusion 
events. Syntaxin, SNAP-25 and VAMP (also called synaptobrevin) were the first SNAREs to 
be discovered 32–34. Syntaxin and VAMP are anchored to membranes by C-terminal 
transmembrane domains, whereas SNAP-25 is attached through post-translational 
palmitoylation of four cysteine residues in its central region 35,36. All SNARE proteins are 
characterised by a ~70 residue “SNARE motif” with heptad repeats that forms coiled-coil 
structures. The SNARE core complex has a four-stranded coiled-coil structure, one coil from 
syntaxin and VAMP and two from SNAP-25. This structure, called “trans-SNARE 
complex”, bridges vesicles and plasma membranes close to each other and catalyses fusion. 
In the course of fusion, the trans-conformation is adjusted to a cis-SNARE conformation with 
all SNAREs located on the same membrane 37. The complex is highly stable and to dissociate 
it requires ATP and two proteins: NSF and its adaptor protein, SNAP-α 14,38. 
1.2.3 SNAP-25 isoforms 
Mice deficient of SNAP-25 exhibit embryonic lethality and evoked synaptic transmission is 
abolished, although they show an early nervous system development and spontaneous 
transmitter release 39. SNAP-25 is expressed as two splicing variants, SNAP-25a and SNAP-
25b, which originate from two divergent versions of exon 5. They differ in only 9 out of 206 
amino acids (Figure 2) corresponding to a central domain of the protein spanning the quartet 
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of cysteine residues that are substrates for palmitoylation and three residues that are part of 
the N-terminal SNARE motif 35,36,40,41.  
 
 
Figure 2. Schematic structure of the Snap25 gene and amino acids sequence encoded by exons 5a and 5b. 
 
Both SNAP-25a and SNAP-25b can participate in the core SNARE complex 42. The 
expression levels of the two isoforms are developmentally and spatially regulated. In rodent 
brain, SNAP-25a is more abundant during early development, but by the second postnatal 
week SNAP-25b becomes the predominant isoform 43,44. SNAP-25a expression remains in 
specific brain regions, such as cortical and hypothalamic structures, and in endocrine and 
most neuroendocrine cells SNAP-25a is the dominant isoform also in adulthood 43,45–47. 
Normal expression levels of total SNAP-25 are essential for controlled synaptic function 48,49 
and downregulation leads to defects in SNARE complex assembly and synaptic plasticity 
48,50. The functional difference between the two splice variants has not been fully clarified. 
What is currently believed is that SNARE complexes containing SNAP-25b are more stable, 
thus increasing the pools of primed vesicles 42,51,52. Recently, a point mutation in SNAP-25b 
carried by a viable mouse mutant, has been associated with impairments in vesicle trafficking 
and regulated membrane fusion, likely dependent on failure to mobilise new vesicles from the 
RP 53. Moreover, SNAP-25 has been found to interact and modulate the activity of Ca2+ 
channels 54–56. The C-terminus of SNAP-25 inhibits L-type Ca2+ currents in beta cell whereas 
the rest of the protein stimulates channel activity 54. Interestingly, it was recently 
demonstrated that the SNAP-25b isoform together with syntaxin 1 was more efficient in 
inhibiting VDCC currents in chromaffin cells than SNAP-25a 56. 
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1.2.4 Regulation of exocytosis by other proteins 
1.2.4.1  Munc18-1 
Munc18-1 belongs to a group of proteins called SM proteins (Sec1/Munc18-like) initially 
identified in genetic screens in yeast 57. It has been linked to membrane fusion since it was 
first isolated bound to syntaxin 1 31. The SM proteins are essential for all types of intracellular 
membrane fusion where also SNAREs are involved and their absence leads to blockage of 
fusion 14 and neurotransmitter release in Munc18-1 knockout mice 58. The general function of 
Munc18-1 is still under debate because it probably performs multiple roles. SM proteins are 
equipped with a conserved  ~600-amino acid sequence that folds into an arch shape and binds 
the closed conformation of syntaxin 1 59,60. This binding with syntaxin 1 disables the 
formation of the SNARE complex. Munc18-1 does not always act as a negative modulator of 
membrane fusion but is also required for all fusion events. More recently, a second 
mechanism of interaction between Munc18-1 and SNAREs was found, explaining how it 
could promote fusion 61,62. Here, the SM protein is anchored to the N-terminal peptide of 
syntaxin, thus leaving its arch-shaped body to fold back on the SNAREpin and clasp across 
the zippering four-helices near the plasma membrane. Thus, SM proteins would act as 
catalysts for SNAREs, which in turn catalyses the membrane fusion event 14.  
1.2.4.2 Heterotrimeric G proteins 
Major modulators of neurotransmitter/hormone action are the G protein coupled receptors 
(GPCRs), which consist of seven transmembrane α-helices 63. Despite the elevated number of 
GPCRs, they are coupled with relatively few heterotrimeric G proteins (α, β and γ subunits). 
The heterotrimers are categorised into four families: Gs, Gi/o, Gq, G12/13, based on the 
functional similarity of the α subunit 64. When the ligand binds, the receptor activates the 
attached G protein which dissociates into one α subunit and a βγ-complex.  Gα can diffuse 
along the membrane surface to activate/inhibit target proteins, often enzymes that generate 
second messengers. The βγ-complex works as a functional monomer also able to affect 
protein activity 63. Gi/o-coupled receptors (5HT1 serotonin receptors, α2A adrenergic receptors, 
D2 dopamine receptors, M4 muscarinic receptors, opioid receptors, etc.) on both pre- and 
postsynaptic sites protect against overstimulation by releasing G protein βγ subunits. These 
subunits act both postsynaptically by activating G-protein-coupled inwardly-rectifying K+ 
(GIRK) channels and presynaptically by inhibiting VDCCs 65,66 or by regulating GIRK 
channels 67. Ultimately they interact with one or more components of the exocytotic 
machinery 63. 
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The first evidence for the latter function of the βγ subunits came from studies on lamprey 
reticulospinal motor neuron synapses where Gβγ inhibition was mediated via the C-terminal 
region of SNAP-25 and the Gβγ subunits directly interacted with the SNARE complex 
proteins in in vitro binding assays 68–71. It was also noted that the syntaxin and SNAP-25 
domains interacting with Gβγ were functionally important for Ca2+-dependent synaptotagmin 
binding 71. Therefore, it was predicted that at low intracellular Ca2+ concentrations, Gβγ 
binding to the SNAREs predominates, but when Ca2+ concentration increases synaptotagmin 
competes with Gβγ, blocking inhibition and allowing exocytosis (Figure 3) 71. 
 
 
Figure 3. Schematic mechanisms of presynaptic inhibition modulated by the Gβγ subunits of the heterotrimeric 
G proteins. Upon ligand interaction with the GPCR, the Gβγ subunit competes with synaptotagmin for binding 
the exocytosis machinery, thus inhibiting fusion. 
 
Inhibition of synaptic transmission via Gβγ is not only important for transient events, but it 
also plays a role in long-term alterations of presynaptic signals connected to long-term 
depression (LTD) 72. Emerging evidence places LTD as fundamental process for modelling 
long-lasting changes in circuit function, learning, memory and behaviour 73. Furthermore, a 
similar mechanism has been proposed for inhibition of insulin secretion in beta cells 74. 
1.3 THE PANCREATIC ISLET 
1.3.1 Cell composition and exocrine pancreas 
The discovery of the islets of Langerhans in the pancreas dates back to 1869, when a German 
medical student, Paul Langerhans, observed cell-clusters disseminated in the rabbit pancreas 
75. They constitute the endocrine part of the pancreas which accounts for 1-2% of the total 
pancreatic volume. Islets are structurally defined cellular aggregates of a few to several 
thousand endocrine cells 76. The islet comprises at least 5 types of polypeptide-hormone-
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secreting endocrine cells and the majority belongs to the population of beta cells (60-80%) 
which secrete insulin, the only blood glucose lowering hormone. Second in number are the 
alpha cells (10-20%), which produce glucagon. Delta cells and PP cells (5%) release 
somatostatin and pancreatic polypeptide, respectively, and finally the epsilon cells (1%) 
which secrete ghrelin 77,78. The intraislet organization of endocrine cells differs among 
species: in rodents, the  islet  core  is  primarily  composed  of  beta cells  while  the  other  
cell  types  are  localised peripherally, in humans all types of cells are intermingled with no 
obvious patterns of organization 79,80,78.  The close arrangement of islet cells facilitates 
intercellular coupling and paracrine interactions 81. 
The islets are embedded in the exocrine pancreas, organised in acini and formed by acinar 
cells which secrete enzymes for food digestion (α-amylase, lipase and proteases). Moreover, 
there exists an extensive cell-cell communication between the endocrine islet and the 
exocrine acinar cells via desmosomes and adherent junctions, which become structurally lost 
during remodelling changes associated with the development of T2D 82. 
1.3.2 Stimulus-secretion coupling in beta cells 
The pancreatic beta cell acts as a metabolic sensor, integrating nutrients, hormones and 
neurotransmitters stimuli to finally secrete insulin. The beta cell is equipped with two distinct 
types of secretory vesicles, the SLMVs containing gamma-aminobutyric acid (GABA) and 
the SGs containing insulin 17.  
Insulin is released following food digestion and glucose acts as the most important nutrient 
secretagogue for beta cells. Blood glucose enters the beta cell via a transporter (GLUT2 is the 
predominant in mice) and starts to be metabolised by phosphorylation, a reaction catalysed by 
the enzyme glucokinase. Once phosphorylated, glucose-6-phosphate, cannot exit the cell and 
undergoes a metabolic process involving the mitochondria and the release of energy in the 
form of ATP 83,84. The increased ATP/ADP ratio promotes the closure of the ATP-sensitive 
K+-channels (KATP-channels) in the plasma membrane. Since these channels maintain a 
resting potential of about -70 mV, their closure leads to a gradual depolarization of the cell. 
With changes in membrane potential, the VDCCs are activated with subsequent increase in 
cytosolic free Ca2+ and finally leading to exocytosis of insulin granules (Figure 4). It has been 
demonstrated that in beta cells L-type Ca2+-channels bind the SNARE core complex via 
syntaxin, SNAP-25 and synaptotagmin with subsequent local increase of [Ca2+]i triggering 
membrane fusion. The site of interaction on the channel is called “synprint” 55. 
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Figure 4. Schematic representation of glucose-stimulated insulin secretion in a beta cell. Glucose enters the cell 
via glucose transporters and is metabolised in the mitochondria with subsequent production of energy (ATP). 
Raise in ATP/ADP ratio closes the KATP-channels, depolarizing the cell membrane which will in turn open the 
VDCCs. Membrane fusion is triggered after Ca2+ enters the cell. 
 
1.3.3 Modes of insulin secretion 
Experiments in isolated pancreatic islets and hyperglycaemic clamps have demonstrated that 
glucose induces insulin secretion in a biphasic pattern: a fast and transient “first phase” 
followed by a sustained and long-lasting “second phase” 7,8,18. Loss of the first phase and 
reduction of the second phase are traits of T2D whereas in obese individual both phases are 
increased 7,8. During the last decades, many different theories have been suggested behind the 
molecular mechanisms of biphasic insulin secretion, yet without a final conclusion. However, 
the most prevailing hypothesis is that the release of the RRP of vesicles (5% of total content), 
docked on the plasma membrane, accounts for the first phase of insulin release and the 
second phase is build up by recruitment of a RP to the plasma membrane 8.  
There are different modes of exocytosis besides the full fusion mode. The “kiss-and-run” 
fusion occurs when the granule-exocytotic machinery complex is not in proximity of VDCCs 
and therefore the fusion pore opens only transiently 85. The “compound” exocytosis has been 
described to correspond to fusion of several granules organised in multivesicular complexes 
85,86. However, the physiological role of the different exocytotic modes and their possible 
involvement in metabolic disease and T2D is still not understood.  
1.3.4 Ca2+ dynamics in beta cells  
Ca2+ impacts nearly every aspect of cellular life. It acts as a secondary messenger controlling 
a number of processes such as secretion, apoptosis and gene expression. As previously 
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mentioned, Ca2+ plays a fundamental role for exocytosis in beta cells as it regulates 
trafficking, docking and initiates fusion of the insulin granules via the SNAREs proteins. Ca2+ 
influx into the cytoplasm has been described to occur rhythmically due to a rhythmic nature 
of the underlying electrical activity 87,88.  Ca2+ sequestration and release from the ER 
contributes to smoothing the oscillations observed in islets and it occurs under the fine 
regulation of the Ca2+ pumps present on the ER, such as the sarcoendoplasmic reticulum (SR) 
Ca2+ transport ATPase, SERCA 89. Yet the exact patter of Ca2+ elevations depends on the 
experimental model employed. Two types of oscillations have been described until now: slow 
oscillations (3-5 min) recorded in single beta cells or cultured islets and fast oscillations (1-2 
min) recorded in freshly isolated islets 90,91. Also, an oscillatory pattern of insulin release, 
driven  by  oscillations  of   [Ca2+]i  has   been   demonstrated,   suggesting   a   refined   
temporal correlation between electrical activity, Ca2+ signalling and insulin secretion  in  
isolated  islets 92,93. Moreover, in vivo experiments have demonstrated similar [Ca2+]i and 
membrane potential oscillations as the ones described in freshly isolated islets 94. A 
considerable degree of synchronicity in electrical activity between different cells in the same 
islet has been shown along with [Ca2+]i oscillations occurring synchronously across the islet 
90,94–96. This extensive communication among beta cells is achieved by means of the gap 
junction protein connexin 36 (Cx36), which allows exchange of small signalling molecules 
such as Ca2+ ions 97. In several mouse models of diabetes 98–100, in Cx36-null mouse models 
101,102 and also in humans with prediabetes 103 the loss of synchronization in [Ca2+]i 
oscillations is accompanied by a disruption of glucose sensitivity and impairment of the 
normal oscillatory pattern of insulin secretion.  
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2 AIMS 
The overall objective of this thesis was to investigate the metabolic consequences of SNAP-
25b-deficiency in order to better understand the role of the two splice variants, SNAP-25a 
and SNAP-25b. The specific aims investigated have been to study: 
 If the replacement of SNAP-25b with SNAP-25a (i.e. a small modification in the 
SNARE complex) could provoke metabolic abnormalities in mice, alone or in 
combination with a high fat/high sucrose diet consumption. 
 
 The effects of SNAP-25b-deficiency on islet physiology and glucose-stimulated 
insulin secretion. 
 
 The binding capabilities of the SNAP-25 isoforms for proteins regulating initiation 
and inhibition of membrane fusion. 
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3 MATERIALS AND METHODS 
All the experiments were carried out in different cohorts of mice and each of them included 
the following groups of 12-week-old mice depending on the paper: SNAP-25b-deficient 
(MT) and wild type (WT) littermates, males and females fed a control (CoD) or high fat/high 
sucrose (Western, WeD) diet. 
3.1 IN VIVO EXPERIMENTS 
3.1.1 Animals 
The SNAP-25b-deficient mice were generated as previously described 52. The animals were 
maintained on a regular dark-light cycle (lights on at 07:00 and off at 19:00) in temperature 
and humidity-controlled rooms with food pellets and tap water ad libitum. MT and WT 
littermates were euthanised by cervical dislocation. Animal studies were done in accordance 
with the guidelines from the local authorities, i.e., the Stockholm Northern Animal 
Experiments Ethics Board, following the approval of the Administration of the Republic of 
Slovenia for Food Safety, Veterinary Sector and Plant Protection (Permit number: 34401-61-
2009/2, 34401-46/2014/4, 34401-12/2015/3) and in accordance with Directive 2010/63/EU of 
the European parliament and of the Council on the Protection of Animals Used for Scientific 
Purposes. 
3.1.2 Diet 
The diet intervention started at the age of 5 weeks, i.e., at adolescence, a critical window for 
the development of metabolic disorders 104. MT and WT mice from each sex were divided 
randomly into two groups with a similar average body weight and were fed either CoD 
(10.5% of kilocalories from fat, 17.7% from proteins; and 71.7% from carbohydrates) or the 
WeD (40.0% of kilocalories from fat; 17.0% from proteins; and 43.0% from carbohydrates) 
for 7 weeks. In Paper I mice were either fed a CoD or WeD, whereas in Paper I and II only a 
CoD. 
3.1.3 Measurement of metabolic parameters  
In Paper I, the mice were housed three per cage, and body weight was monitored for each 
genotype and sex twice a week during the whole time course of the diet intervention. At the 
end of the study, the BMI was calculated. Nonfasting blood glucose was determined once a 
week during the 7 weeks of diet intervention in blood obtained from the tail vein at the start 
of the dark cycle (7:00 PM) with a FreeStyle Glucometer (Abbott Diabetes Care, Witney, 
United Kingdom). Preprandial blood triglycerides and cholesterol levels were determined 
  13 
using a multiparameter diagnostic device for triglycerides and cholesterol (multiCare-in, 
Biochemical Systems International, Florence, Italy) from the tail vein. At the end of the diet-
intervention study, this cohort of animals was subjected to 12 h overnight starvation, and then 
basal blood triglycerides and cholesterol levels were determined.  
3.1.4 Feeding pattern and caloric intake 
In Paper I, mice were placed in individual cages and food intake was determined twice a 
week. Because the calorie intake differed between the two diets, daily calorie consumption 
was calculated as the kilocalories ingested daily by each mouse. Finally, calorie efficiency 
was determined to establish the relationship between body weight gain and calories 
consumed by each animal (Δ body weight/kcal). All these parameters were corrected for the 
body weight of each individual animal in each experimental group. The male MT mice fed a 
CoD became overweight, despite that their average food intake was significantly lower than 
WTs. Thus, we monitored their daily food intake, body weight, and body weight gain at 7:00 
AM (after the active period) and at 7:00 PM (after the inactive period).  
3.1.5 Glucose tolerance tests and serum insulin levels 
In Paper I, mice were starved 12 h overnight and the basal blood glucose (0 time point) was 
measured in blood samples collected from the tail vein. Thereafter, mice received an 
intraperitoneal glucose injection (2 g/kg body weight), and blood glucose was measured after 
15, 30, 60, 90, and 120 min. Blood glucose levels were determined using a FreeStyle 
Glucometer (Abbott Diabetes Care, Witney, United Kingdom). Blood was collected at the 
same time points as in the glucose tolerance test (GTT), centrifuged for 20 min, 10,000 x g at 
4 °C and serum was frozen at -80 °C until use. Serum insulin levels were analysed using an 
ultrasensitive mouse insulin ELISA kit (Crystal Chem Inc., Downers Grove, IL, USA). The 
HOMAIR was calculated using the formula: fasting insulin (mU/L) × fasting blood glucose 
(mmol/L)/22.5. The AUC was calculated using the basal levels of blood glucose and serum 
insulin as baselines.  
In Paper II, a “first phase” GTT was performed on mice starved 12 h overnight. One hour 
before glucose injection, EMLA cream (25 mg lidocaine and 25mg prilocaine, AstraZeneca, 
London, United Kingdom) was applied on the tail (to minimise stress) and after 15 min basal 
blood glucose was measured. After 45 min mice were injected intraperitoneally with glucose 
(2g/kg body weight) and blood glucose levels were determined at 0, 2.5, 5, 7.5, 10, 15 min. 
Serum insulin, HOMAIR and AUC were measured as in Paper I.  
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3.2 EX VIVO EXPERIMENTS 
3.2.1 Total pancreas insulin content 
The whole pancreas was dissected out and homogenised in 1.4 ml of acid ethanol containing 
75% (v/v) ethanol in 0.2 M HCl until no big pieces were observed. The pancreas 
homogenates were sonicated (frequency: 30 Hz; 12 pulses) (Branson Sonifier Cell Disruptor 
B15; Branson Ultrasonic, Danbury, CT, USA) and diluted at 1:5,000, 1:10,000, and 1:20,000 
for insulin measurement with an ultrasensitive mouse insulin ELISA kit (Crystal Chem Inc., 
Downers Grove, IL, USA). Protein levels in each pancreas homogenate were measured by 
the Bradford method, and the total pancreas insulin content (ng/ml) obtained from ELISA 
immunoassay was normalised to the total protein concentration (mg/ml) of each extract.  
3.2.2 Body fat distribution 
Subcutaneous (ScAT) and visceral (mesenteric, MsAT, retroperitoneal, RpAT and 
perigonadal PgAT) white adipose tissues were dissected out quickly and weighted. 
Afterwards, they were frozen in liquid nitrogen and kept at −80 °C until use.  
3.2.3 Leptin and ghrelin in serum 
For leptin and ghrelin measurements, multiplex immunoassays (BioPlex Pro, Bio-Rad 
Laboratories, Hercules, CA, USA) were run with blood samples taken randomly from 
animals belonging to the different cohorts, always after a 12 h period of overnight starvation.  
3.2.4 Triglycerides content in liver 
The left lobe of each liver (100-300 mg) was dissected out, immersed quickly in 350 μl of 
ethanolic KOH [0.1 M potassium hydroxide (Sigma-Aldrich, ST. Louis, MO, USA) in 
absolute ethanol (Merck, Darmstadt, Germany)], and incubated overnight at 55 °C until no oil 
layer was visible. After homogenization, each sample was brought up to 1 ml with a 1:1 
ethanol:water solution, vortexed, and centrifuged at 4 °C (7,000 × g) for 5 min. The 
supernatant was moved to another tube, and again the volume was brought up to 1.2 ml with 
a 50% (v/v) ethanol solution. 200 μl of each sample were neutralised with 215 μl of 1 M 
MgCl2 solution, vortexed, and left on ice for 10 min. After incubation, samples were 
centrifuged under the conditions described above, and the supernatant was moved to a new 
tube. Free liver triglycerides were analysed using Free Glycerol Reagent and Glycerol 
Standards (Sigma-Aldrich, ST. Louis, MO, USA) to construct the standard curve. The 
glycerol concentration in each cuvette (triolein equivalents) was measured by 
spectrophotometry (SAFAS-MONACO spectrophotometer, Monaco, France) at a wavelength 
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of 540 nm and was determined by extrapolation with the standard curve. Total triglycerides 
content expressed in milligrams per gram of liver was calculated.  
3.2.5 Isolation and cultivation of islets of Langerhans 
After sacrifice, abdomen was accessed via laparotomy and collagenase P (1 mg/ml) (Roche, 
Mannheim, German) diluted in HBSS pH 7.4 (Thermo Scientific, Waltham, MA) was 
injected into the proximal common bile duct clamped distally at the major duodenal papilla of 
Vater. After injection, the pancreas was extracted and incubated in HBSS at 37 °C for 30 min 
without shaking. Ice-cold HBSS (without BSA) was added and 1-2 strokes with 18G needle 
was applied to dislodge islets attached to the tissue. After 4 washes (2 with HBSS without 
BSA and 2 with HBSS 0.5% BSA) islets were hand-picked under a stereo microscope 
(KL200 LED, Leica, Wetzlar, Germany). Purified islets were transferred into petri dishes 
containing RPMI-1640 (Thermo Scientific, Waltham, MA, USA) with a final concentration 
of heat inactivated foetal bovine serum (10%), glutamine (2 mM), penicillin (100 U/ml) and 
streptomycin (100 μg/ml) (Thermo Scientific, Waltham, MA, USA) and incubated at CO2 
(5%) and 37 °C overnight. 
3.2.6 Dynamic insulin secretion assay 
After overnight incubation, approximately 80 islets from each pancreas were transferred to a 
chromatograph column (PERI-4.2, BioRep technologies, Miami Lakes, FL, USA) filled with 
Bio-Gel P-4 (Bio-Rad Laboratories, Hercules, CA, USA) to stabilise them during the 
perifusion. Islets were pre-perifused with NaCl (125 mM), KCl (5.9 mM), CaCl2 (1.28 mM), 
MgCl2 (1.2 mM), HEPES (25 mM), BSA (0.1%) and glucose (3 mM), pH 7.4 for 45 min at 
37 °C. The islets were perifused in the buffer above for 12 min, then sequentially exposed to 
11 mM glucose for 35 min followed by 3 mM glucose for 15 min and the protocol finished 
with 25 mM KCl + 3 mM glucose for 15 min to fuse all possible insulin granules. Fractions 
(50 μl) of the perifusates were collected every min during stimulation in a 96-well plate. The 
collected fractions were then measured for insulin concentration by the AlphaLISA detection 
kit (PerkinElmer, Waltham, MA, USA) with a plate reader (EnVision2103, PerkinElmer, 
Waltham, MA, USA).  
3.3 HISTOLOGY AND IMMUNOHYSTOCHEMISTRY  
3.3.1 Adipocyte size quantification 
After dissection, ScAT and PgAT tissues were formalin-fixed by immersion for 2 weeks. 
After fixation, both ScAT and PgAT were placed in 10% (v/v) sucrose-impregnated 
cardboard blocks, frozen in dry ice, and stored at −80 °C until use. Tissues were sectioned at 
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20-μm thickness using a cryostat (Microm HM500M/CryoStar NX70, Thermo Scientific, 
Waltham, MA, USA) and thawed onto SuperFrost Plus microscope slides (VWR 
International, Radnor, PA, USA). Slides were stained with H&E (Histolab, Gothenburg, 
Sweden) and mounted in VectaMount permanent mounting medium (Vector Laboratories, 
Inc., Burlingame, CA, USA). The stained adipocytes were analysed in an optical microscope 
(Leica, Wetzlar, Germany), and images were obtained at 10× and 40× magnification 
objectives. The area of the adipocytes (in square micrometres) was analysed using the ImageJ 
program (National Institutes of Health, Bethesda, MD, USA), and images were obtained with 
the 10× magnification objective.  
3.3.2 Oil red “O” staining in liver 
For lipid visualization, oil red “O” (ORO) staining was conducted on 14-μm-thick liver 
sections. Before sectioning, liver samples from the left lobe of each animal were dissected out 
and formalin-fixed for 24 h. Sections were obtained as in 3.3.1. After 1 h at room temperature 
slides were rinsed in 60% (v/v) isopropyl alcohol, stained in freshly prepared 0.1% ORO 
solution (Sigma-Aldrich, ST. Louis, MO, USA) for 15 min, rinsed in 60% (v/v) isopropyl 
alcohol, washed in distilled water, and mounted with 0.25% DABCO mounting medium 
(Sigma-Aldrich, ST. Louis, MO, USA). Liver sections from all experimental groups were 
analysed, and lipid droplets were identified using a 5× objective (Leica) followed by 
amplification to 10× and 40× magnification.  
3.3.3 Analysis of islets parameters 
For histological and immunohistochemical analysis, the animals were perfused and the 
pancreas treated as described in 3.3.4. Thaw-mounted 16 μm sections were dried at room 
temperature for 30 min and rinsed with PBS for 15 min.  Mounted sections were incubated 
with primary antibodies in a humidified chamber at 4 °C overnight (rabbit anti-glucagon 
antibody, 1:1,000 dilution, BioGenex, Fremont, CA, USA and guinea-pig anti-insulin 
antibody, 1:200 dilution, Bio-Yeda, Rehovot, Israel). After washing in PBS, they were 
incubated with secondary antibodies for 90 min at room temperature (donkey Cy3-conjugated 
anti-rabbit IgG and donkey FITC-conjugated anti-guinea pig IgG, 1:150 and 1:40 dilution 
respectively, Jackson Immunoresearch Europe, Suffolk, United Kingdom). Sections were 
finally incubated with DAPI (1:10,000 dilution, Bio-Rad, Hercules, CA, USA) diluted in PBS 
for 15 min at room temperature and mounted using 2.5% DABCO in glycerol (Sigma-
Aldrich, ST. Louis, MO, USA). For the detection of apoptotic beta cells, sections were 
processed according to the instructions in the commercial kit used (Click-iT Plus TUNEL 
assay, Thermo Scientific, Waltham, MA) and co-labeled with insulin. For histology, another 
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set of sections was used for H&E staining (Histolab, Gothenburg, Sweden) and mounted with 
VectaMount permanent mounting medium (Vector Laboratories Inc., Burlingame, CA, 
USA).  
The pancreatic sections were examined with Nikon Eclipse E600 fluorescence microscope 
with objective lenses 20× (Nikon, Tokyo, Japan) equipped with appropriate filters and 
ORCA-ER, C4742-80 digital camera (Hamamatsu Photonics K.K., Shizuoka, Japan), using 
Hamamatsu Photonics Wasabi 150 software. Images were also acquired by use of upright 
laser scanning confocal microscope based on a Leica TCS-SP5 II (Leica Microsystems, 
Wetzlar, Germany), together with long-distance water-dipping objectives (Leica HXC-APO 
20×/0.5, Wetzlar, Germany), and a Leica LAS software (Leica, Wetzlar, Germany). For 
insulin- and glucagon-expressing cell quantifications, one randomly-chosen pancreatic 
section/animal was used, each insulin/glucagon positive cell with detectable nucleus was 
counted and the number of cells was divided by the islet area. Two randomly-chosen H&E 
stained pancreatic sections/animal were used for islet size measurement and number of islet 
per section. Around 400 islets were counted. All measurements were done with the ImageJ 
program (National Institutes of Health, Bethesda, MD, USA). For the detection of apoptotic 
beta cells, one randomly-chosen pancreatic section/animal was used and all islets within a 
section were analysed. 
3.3.4 Proximity ligation assay 
For histological and immunohistochemical analyses, mice were deeply anesthetised with 
isofluorane and transcardially perfused with 20 ml of warm (37 °C) PBS, pH 7.4, followed by 
20 ml of a warm mixture of 4% paraformaldehyde (37 °C) and 0.4% picric acid in 0.16 M 
phosphate buffer (pH 7.2), and then by 50 ml of the same, but ice-cold fixative. The pancreas 
was dissected out and postfixed in the same fixative for 90 min at 4 °C. Specimens were 
subsequently stored in 10% sucrose in PBS (0.1 M, pH 7.4) containing 0.01% sodium azide 
(Sigma, St. Louis, MO, USA) and 0.02% bacitracin (Sigma) as preservatives at 4 °C for 2 
days. Coronal sections (14 μm thick) were cut as described in 3.3.1. Afterwards, they 
underwent the protocol for proximity ligation assay (PLA) (DuoLink in situ bright-field, 
Sigma-Adrich, MO, USA). Primary antibodies against Gβ1-4 (1:150 dilution, M-14, Santa 
Cruz Biotechnology, Dallas, TX, USA) and SNAP-25 (1:1,000 dilution, SMI-81, Biolegend, 
San Diego, CA, USA) were used. 
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3.4 PROTEIN ANALYSES 
3.4.1 Western blotting in hypothalamus and liver 
In Paper I, hypothalamus and liver samples from all experimental groups were homogenised 
in ice-cold buffer containing 0.42 mM NaCl, 20 mM Hepes (pH 7.9), 1 mM Na4P2O7, 1 mM 
EDTA, 1 mM EGTA, 1 mM DTT, 20% (v/v) glycerol, 1 μg/ml aprotinin, 1 μg/ml leupeptin, 
20 mM sodium fluoride, 1 mM trisodium orthovanadate, and 2 mM phenylmethylsulfonyl 
fluoride. Tubes containing homogenates were exposed to a thermal shock at −80 °C in liquid 
nitrogen and thawed to 37 °C three consecutive times, and centrifuged at 10,000 × g for 20 
min. Then the supernatant was collected. Protein levels in the supernatant of both liver and 
hypothalamus homogenates were measured by the Bradford method, and volumes were 
adjusted in Laemmli buffer [50 mM Tris (pH 6.8), 10% (v/v) SDS, 10% (v/v) glycerol, 5% 
(v/v) mercaptoethanol, and 2 mg/ml bromophenol blue] to 2 μg/μl of protein concentration. 
Proteins (40 μg) were loaded using a Trans-Blot apparatus (Bio-Rad). Each sample was size-
separated in 10% (v/v) SDS/PAGE and transferred to PVDF membranes (GE Healthcare, 
Little Chalfont, United Kingdom). For immunoblotting, membranes were blocked with 5% 
(w/v) nonfat dried milk. Primary antibodies against total and phosphorylated (Thr172) forms 
of AMPK-α1/2 (1:1,000 dilution, Cell Signaling, Danvers, MA, USA), total and 
phosphorylated (Tyr705) STAT3 (1:1,000 dilution, Santa Cruz Biotechnology, Dallas, TX, 
USA), total and phosphorylated (Thr202/Tyr204) ERK1/2 (1:1,000 dilution, Cell Signaling, 
Danvers, MA, USA), or ObR (1:1,000 dilution, Santa Cruz Biotechnology, Dallas, TX, USA) 
were applied overnight. After incubation with IgG–peroxidase complexes, blots were 
incubated in commercial enhanced chemiluminescence reagents (ECL-Prime; GE Healthcare, 
Little Chalfont, United Kingdom), and membranes were exposed to a luminescent image 
analyser (Las-1000 Plus; Fuji, Tokyo, Japan). Obtained images were quantified using ImageJ 
software. Values for all proteins were normalised to β-actin (1:1,000 dilution, Sigma-Aldrich, 
ST. Louis, MO, USA).  
3.4.2 Western blotting and immunoprecipitation in hippocampus 
In Paper III, hippocampi were quickly dissected and homogenised in ice-cold buffer 
containing: 50 mM Tris-HCl (pH 7.4), 180 mM NaCl, 0.25% NP-40, 20% glycerol, 1 mM 
MgCl2, 2 mM EDTA, 0.035% β-Mercaptoethanol, 0.5 mM phenylmethanesulfonylfluoride 
and proteases inhibitor cocktail (1 tablet/10ml; Roche, Basel, Switzerland) by using Kontes 
pellet pestle homogeniser (Sigma-Aldrich, St. Louis, MO, USA). Protein concentration was 
assessed as in 3.4.1 and adjusted with the lysis buffer to a final concentration of 2 µg/µl. One 
ml of precleared protein extracts was incubated overnight at 4 °C under rotation with 50 µl of 
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protein G-sepharose slurry (GE Healthcare, Little Chalfont, United Kingdom) preincubated 
with 1 µg of anti-SNAP-25 antibody (SMI-81, Biolegend, San Diego, CA, USA) diluted in 
50 µl of TBS buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl). After four washes with TBS 
buffer supplemented with 0.05% Triton X-100, 25µl of Laeammli buffer was added to the 
precipitated proteins (0.5 M Tris-HCl pH 6.8, 20% glycerol, 4% SDS, 10% β-
Mercaptoethanol and 0.05% bromophenol blue) and heated at 100 °C for 20 minutes. Protein 
eluates were centrifuged 3 min at 6000 rpm and 15 µl were loaded on 4-12% Bis-Tris 
gradient gels (NuPage, Thermo Fisher Scientific, Waltham, MA, USA) and run for 45 min at 
200 V with 2-(N-morpholino)ethanesulfonic acid (MES) buffer (NuPage, Thermo Fisher 
Scientific, Waltham, MA, USA). For silver staining the gels were processed as described in 
the protocol (SilverQuest™ Silver Staining Kit, Thermo Fisher Scientific, Waltham, MA, 
USA). Proteins were transferred onto nitrocellulose membranes by using the iBlot gel transfer 
technique (Thermo Fisher Scientific, Waltham, MA, USA). For immunoblotting, membranes 
were blocked with 5% nonfat dried milk in 0.1% Tween-PBS (4.3 mM Na2HPO4, 137 mM 
NaCl, 2.7 mM KCl and 1.4 mM KH2PO4, pH 7.4) for 2 h at room temperature. Primary 
antibodies against syntaxin 1 (1:500,000 dilution, Synaptic Systems, Göttingen, Germany), 
VAMP-2 (1:1,000,000 dilution, Synaptic Systems, Göttingen, Germany) Munc18-1 
(1:10,000 dilution, Synaptic Systems, Göttingen, Germany) Gβ1-4 (1:500 dilution, M-14, 
Santa Cruz Biotechnology, Dallas, TX, USA), and SNAP-25 (1:1,000,000 dilution, SMI-81, 
Biolegend, San Diego, CA, USA), were applied overnight at 4 °C under shaking. After 
incubation with anti-mouse or anti-rabbit IgG-peroxidase complexes (GE Healthcare, Little 
Chalfont, United Kingdom), immunoreactive bands were processed as described in 3.4.1. 
Values for Gβ1-4 band densitometry were normalised to SNAP-25 band densitometry. 
For analysing expression levels of hippocampal proteins, 15 µg of protein from lysates were 
loaded and run on gradient gels with the same materials and conditions as for the 
immunoprecipitation described above. Primary antibodies against Munc18-1 (1:10,000), 
syntaxin 1 (1:100,000), VAMP-2 (1:1,000,000), SNAP-25 (1:1,000,000) and Gβ1-4 (1:5,000) 
and α-tubulin (1:1,000 dilution, Santa Cruz Biotechnology, Dallas, TX, USA) were used. 
Values for the proteins band densitometry were normalised to α-tubulin. 
3.4.3 Mass spectrometry 
Samples were analysed at Proteomics Karolinska, PK/KI core facility at Karolinska Institutet, 
Stockholm, Sweden. The silver-stained protein band was cut from the gel and the piece was 
digested using MassPREP robotic protein handling system (Waters, Millford, MA, USA). 
Briefly, washing was carried out in 50 mM ammonium bicarbonate containing 50% 
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acetonitrile. The protein was reduced (DTT) and alkylated (iodoacetamide) followed by in-
gel digestion with 0.3 mg trypsin (Promega, Madison, WI, USA) in 50 mM ammonium 
bicarbonate for 5 h at 40 °C. The tryptic peptides were extracted with 1% formic acid/2% 
acetonitrile, followed by 50% acetonitrile twice. The liquid was evaporated and the peptides 
were injected onto the LC-MS/MS system (EASY-nLC chromatography system and Orbitrap 
Velos Pro API mass spectrometer, Thermo Scientific, MA, USA). The peptides were 
separated on a homemade C18 column, 8 cm (Silica Tip 360 µm OD, 75µm ID, New 
Objective, Woburn, MA, USA) and the effluent electrosprayed into the mass spectrometer 
direct via the column. The spectra were analysed using Mascot (Matrix Science) and searched 
against SwissProt_2014_01, mus musculus.  
3.5 ELECTROPHYSIOLOGY AND CA2+ IMAGING IN BETA CELLS 
3.5.1 Pancreatic tissue slice preparation 
A low-melting point agarose (1.9 %, Lonza Rockland Inc., Rockland, ME, USA) in 
extracellular solution, ECS, consisting of: NaCl (125 mM), NaHCO3 (26 mM), glucose (6 
mM), lactic acid (6 mM), myo-inositol (3 mM), KCl (2.5 mM), Na-pyruvate (2 mM), CaCl2 
(2 mM), NaH2PO4 (1.25 mM), MgCl2 (1 mM), ascorbic acid (0.5 mM) at 40 °C was injected 
into the proximal common bile duct clamped distally at the major duodenal papilla of Vater. 
Immediately thereafter, the pancreas was cooled using ice-cold ECS and extracted. Small 
tissue blocks were plunged into the agarose at 40 °C and cut with a VT 1000 S vibratome 
(Leica, Nussloch, Germany) into 140 μm-thick slices of a surface area of 20-100 mm2. 
Throughout the procedure, tissue was held in an ice-cold ECS continuously bubbled with a 
gas mixture containing O2 (95%) and CO2 (5%) at barometric pressure to ensure oxygenation 
and a pH of 7.4. After cutting the slices were collected in 30 ml of HEPES-buffered saline, 
HBS, consisting of: NaCl (150 mM), HEPES (10 mM), glucose (6 mM), KCl (5 mM), CaCl2 
(2 mM), MgCl2 (1 mM); titrated to pH 7.4. All chemicals were obtained from Sigma-Aldrich 
(St. Louis, MO, USA) unless indicated. 
3.5.2 Electrophysiology 
Patch pipettes were pulled from borosilicate glass capillaries (GC150F-15, Harvard 
Apparatus, Holliston, MA, USA) using a horizontal pipette puller (P-97, Sutter Instruments, 
Novato, CA, USA). The pipette resistance was 2–3 MΩ in Cs+-based solution. Fast pipette 
capacitance (Cfast) was compensated in cell-attached mode, slow membrane capacitance 
(Cslow) and series conductance (Gs) were compensated after establishment of whole-cell 
mode. Only experiments with Gs>50 nS were carried out. Recordings were performed in the 
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standard whole-cell mode via a patch-clamp lock-in amplifier (SWAM IIc, Celica, Slovenia) 
connected to a computer via A/D converter (16 bit, NI USB-6343, X Series Multifunction 
DAQ, National Instruments, Austin, TX, USA) and recorded on the hard disk using 
WinWCP V5.1.6 software (John Dempster, University of Strathclyde, United Kingdom). The 
same software was used for identifying beta cells by their Na+ current inactivation properties 
and for determining membrane capacitance change after slow photo-release of caged Ca2+. A 
continuous sine voltage (1600 Hz, 11 mV RMS amplitude) was applied to measure Cm. 
Resting membrane potential in voltage-clamp mode was -80 mV. The pipette solution used 
for Ca2+-induced capacitance and current measurements was composed of NP-EGTA (5 
mM), CaCl2 (4 mM), mM Fura 6F (0.1) (Invitrogen, Eugene, OR) together with CsCl (125 
mM), HEPES (40 mM), MgCl2 (2 mM), TEA–Cl (20 mM), Na2ATP (2 mM) at pH 7.2 and 
osmolality 300 ± 10 mOsm. Signal processing and curve fitting was done using Matview 
(Wise Technologies, Ljubljana, Slovenia) and Matlab (The MathWorks, Inc., Natick, MA, 
USA). 
3.5.3 Loading of dyes and imaging of [Ca2+]i oscillations in beta cells 
For [Ca2+]i imaging 8-10 slices were incubated in a petri dish filled with HBS (3.333 ml) 
containing Oregon Green 488 BAPTA-1 acetoxymethyl ester calcium fluorescent dye (6 μM, 
OGB-1, Invitrogen, Eugene, OR, USA), Pluronic F-127 (0.03 % w/v) and 
dimethylsulphoxide (DMSO, 0.12% v/v) for 50 min on an orbital shaker (50 turns min-1) at 
room temperature and protected from light. Ca2+ imaging was performed on a Leica TCS SP5 
AOBS Tandem II upright confocal system using a Leica HCX APO L 20× water immersion 
objective (NA = 1.0). OGB-1 was excited by an argon 488 nm laser and the emitted light was 
detected by Leica HyD hybrid detector in the range of 500-700 nm (all from Leica 
Microsystems GmbH, Wetzlar, Germany). The slices were perifused with bubbled ECS at 
35-37 °C containing 6-12-6 mM glucose, sequentially. Only cells lying at least 15 μm below 
the surface were imaged. Images were acquired at a spatial resolution of 512 × 512 pixels and 
a temporal resolution of 1 Hz. The total time of 12 mM glucose stimulation was 15-22 min. 
To determine the frequencies and the durations of Ca2+ oscillations and for the network 
analysis, images were acquired for 5 min at a spatial resolution of 256 × 256 pixels and a 
temporal resolution of 29 Hz. Time traces were analysed off-line from regions of interest with 
Leica Application Suite Advanced Fluorescence software (Leica Microsystems GmbH, 
Wetzlar, Germany), exported and further examined to determine the delays in the onsets and 
delays in deactivation in the [Ca2+]i responses using MATLAB (The MathWorks, Inc., 
Natick, MA, USA). Traces were corrected for photobleaching of the dye employing a 
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combination of linear and single exponential fit 90. Signals were expressed as (F – F0)/F0 
ratios, where F0 is the initial fluorescence intensity and F is the fluorescence signal recorded 
at an individual time point. All recorded time series were digitally band-pass filtered in order 
to remove noise and artefacts, and then additionally smoothed with an adjacency averaging 
procedure. To calculate the frequencies and durations of Ca2+ oscillations, the onsets and the 
endings of individual oscillations were defined as the time in which the signal decreases 
bellow the half of the maximal amplitude in the given oscillation. In this manner, the activity 
profiles of all cells were binarized, whereby the time between the onset and ending of an 
oscillation was denoted as 1, whilst 0 otherwise. The cells with a low signal-to-noise ratio 
were excluded from further analyses. 
3.5.4 Synchronization and functional connectivity of beta cells 
The level of synchronization among beta cells was determined on the basis of binarised Ca2+ 
activity by means of the coactivity matrix, whose ij-th element is defined as follows: 
TiTj
TijCij   
and reflects synchronization between the i-th and the j-th cell. In the equation, Tij stands for 
the total coactivity time in which both cells were simultaneously active and Ti  and Tj  are the 
total individual activity times for both cells. If 0Cij  then no correlation between the i-th 
and j-th cells exists, whilst 1Cij  signifies completely synchronous and aligned dynamics. 
To describe the global level of synchronization in the whole slice, the mean coactivity was 
calculated by averaging over all cell pairs (Figure 5). 
 
Figure 5. Quantification of the Ca2+ traces in beta cells. The grey lines represent the recorded Ca2+ traces of two 
active beta cells upon glucose stimulation. The black lines represent the traces after removal of noise and 
smoothening. Traces were then binarised. The level of synchronization among beta cells was calculated as the 
coactivity coefficient, which measures the overlap of activity (Tij, violet area) of i-th (Ti, green area) and j-th (Tj, 
orange area). Supplementary figure from Paper II. 
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To get a more detailed insight into the intercellular interaction patterns, functional 
connectivity maps were constructed. Two cells were considered to be functionally connected 
if their activity profiles showed a high enough degree of synchronization, i.e. Cij exceeded a 
given threshold value. A variable connectivity threshold was used in order to ensure that all 
examined beta cell networks had the same mean number of connections per cell – 6.  The 
segregation of beta cell networks was assessed by calculating a global metric called 
“modularity”, as proposed by Blondel et.al. 105. A higher modularity indicated a high degree 
of sub-compartmentalization, whereas close-to-zero values indicated an integrated and a 
module-free network. 
3.6 STATISTICAL ANALYSES 
In Paper I, StatView 5.0 software was used for statistical analyses. Cell-line charts were 
analysed by repeated-measures ANOVA. For time point by time point analysis, two-way 
ANOVA was used. Cell bar charts were analysed by two-way ANOVA. Unpaired t-test 
analysis was used to compare one experimental group with its corresponding control group 
during physiological conditions. Statistical significance was verified with nonparametric 
statistics using the Kruskal–Wallis H-test, followed by the post hoc Mann–Whitney, Fisher’s 
protected least significant difference, and Student–Newman–Keuls tests. Bonferroni 
correction was applied in all statistical analyses. The variance between groups was tested 
using Bartlett’s test and was examined in all datasets. Normal distribution was verified by 
using the Kolmogorov–Smirnov normality test. 
In Paper II and III, all statistical analyses were done using GraphPad Prism (GraphPad 
Software, San Diego, CA, USA). Two-way ANOVA followed by Bonferroni multiple 
comparisons test, Mann-Whitney and Student´s t-test were used to verify statistically 
significant differences in all our experiments dependently on non-Gaussian or Gaussian 
distribution of data. The level of significance was set at a P value < 0.05.  
3.7 SCHEMATIC METHODOLOGICAL APPROACH 
The schematic methodological approach for each study is illustrated in Figure 6 (Paper I), 






Figure 6. Methodological approach in Paper I. 
 
                         
Figure 7. Methodological approach in Paper II. 
 
 
Figure 8. Methodological approach in Paper III. 
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4 RESULTS AND DISCUSSION 
4.1 PAPER I 
Deregulation of hormonal secretion, such as insulin, is regarded as a secondary sign and 
consequence of developing metabolic syndrome 8. In Paper I, we instead explored if a small 
modification in the exocytosis machinery could provoke metabolic syndrome, therefore 
acting as a genetic predisposition. We took advantage of MT mice which express SNARE 
complexes only formed by SNAP-25a in neuronal, neuroendocrine and endocrine cells 52. 
Little is known about the functional difference between SNAP-25a and SNAP-25b, yet 
SNAP-25a was found to have a lower capacity to keep vesicles in a primed state 42. We 
monitored WT and MT mice for 7 weeks from the age of 5 weeks. We started the diet 
intervention during adolescence since it is a critical window for the development of metabolic 
syndrome 104,106. Both male and female mice were either administered a CoD or a WeD. We 
found that SNAP-25b-deficiency provoked a set of symptoms characteristic of the human 
metabolic syndrome, exacerbated when combined with WeD. Interestingly, a number of 
polymorphisms in genes encoding proteins important for insulin exocytosis (including 
SNAP-25) have been linked to the severity of certain metabolic traits in T2D/obese patients 
or susceptibility for T2D 107–111. It is therefore tempting to speculate that in humans such 
mutations, in combination with hypercaloric diets, can contribute to the initial phase of 
development of metabolic syndrome.  
4.1.1 SNAP-25b-deficient mice develop obesity and impaired insulin and 
glucose homeostasis 
At the beginning of the study, at the fifth postnatal week, WT and MT mice showed similar 
body weights and blood glucose/triglycerides/cholesterol levels. During the intervention, we 
noticed that MT mice fed a CoD had significantly higher body weights compared to WTs. 
The body weight gain in WeD-fed WTs was similar to the CoD-fed MTs, whereas WeD-fed 
MT mice dramatically increased their body weights compared to all other experimental 
groups. We monitored insulin and glucose homeostasis by challenging 11-week-old mice 
with a standard GTT and concomitant collection of serum from the tail vein to analyse insulin 
levels. Already at basal conditions, all groups of females demonstrated a significant increase 
in basal blood glucose compared to CoD-fed WTs, whereas in males the effect was 
significant only in WeD-fed MTs. The basal insulin levels were increased in all groups 
compared to CoD-fed WTs but only in males WeD-fed MTs it was statistically significant. 
When challenged with glucose, both male and female MTs on CoD exhibited significantly 
lower blood glucose levels compared to WTs after 15 min which was accompanied by 
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elevated serum insulin levels. This suggested that the presence of SNAP-25a alone can favour 
insulin exocytosis at a lower stimulatory threshold. When the animals were fed a WeD the 
glucose clearance was dramatically impaired. Moreover, we found increased total pancreas 
insulin content in MT mice. By monitoring preprandial blood glucose levels for 7 weeks of 
diet intervention, we found that MT mice developed hyperglycaemia compared to CoD-fed 
WT mice. We could disclose both genetic and diet influences in the development of 
hyperglycaemia in males and females. The inability of maintaining normal blood glucose 
suggested insulin resistance and/or impaired eating habits. Indeed, the HOMAIR revealed 
only a tendency to insulin resistance in males but a robust effect in MT-CoD females 
compared to WT-CoD. 
4.1.2 SNAP-25b-deficient mice display altered eating habits correlated to 
hypothalamic dysfunctions 
To explain the increased body weight in MT-CoD as well as MT-WeD mice, we investigated 
their eating habits. In males, the average food and calorie intake of the CoD-fed MTs was 
significantly lower than that of the CoD-fed WTs whereas in the MT females the result was 
opposite, partially explaining their body weight gain. Monitoring the male CoD-mice every 
day for 7 days, enabled us to find that in WTs, the calorie intake was mainly associated with 
the dark active period whereas in MTs it was equally distributed during both the light and 
dark period, suggesting a disruption of the circadian feeding behaviour.  
We therefore hypothesised that the lack of SNAP-25b could induce alterations in feeding 
circuits in hypothalamic neurons hence influencing the mouse metabolic homeostasis 3,112. A 
hallmark for metabolic dysfunction is the activation/phosphorylation of a master metabolic 
regulator, AMPK, regarded as a key protein in the leptin signalling pathway 113,114. The 
activation status of AMPK-1/2 subunit in the hypothalamus after 7 weeks of diet intervention 
was compromised in a sex-independent manner in all groups when compared to CoD-fed 
WTs. We further investigated the status of the leptin receptor, ObR, since it is well described 
that genetic and diet-induced obesity account for increased leptin levels and consequent leptin 
resistance in a tissue specific manner 115. In hypothalamus, the long isoform of ObR, ObRb, 
was found to be affected by WeD intervention in a similar manner in WTs and MTs in both 
sexes, but with the MTs having the most dramatic ObRb deficiency. We further characterised 
the expression levels of key proteins in the insulin/leptin signalling pathways such as STAT3 
and ERK1/2. The phosphorylated STAT3 was reduced in all groups compared to CoD-fed 
WTs, except for male CoD-fed MT mice. The phosphorylated form of ERK1/2 was increased 
in all experimental groups, a phenomenon described as a low-grade inflammation in the 
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hypothalamus of individuals with obesity and T2D 116. Taken together, our results suggest 
that the effects of SNAP-25b-deficiency in combination with WeD are accompanied by 
disruption of cross-talk between the brain (in particular the hypothalamus) and the periphery. 
These results are in line with work from other groups where diet-induced obesity and insulin 
resistance induce permanent effects both on the periphery and the brain.  
4.1.3 SNAP-25b-deficiency leads to adiposity accumulation and 
dyslipidaemia  
As SNAP-25b-deficiency alone provoked obesity, we dissected visceral and nonvisceral fat 
depots from all experimental groups and weighted them in correlation to the body weight of 
each individual mouse. MT mice had a significant increased weight of all white adipose 
tissues, in both sexes, compared to CoD-fed WT mice and when they were fed a WeD the 
resulting adiposity accumulation was even greater. Obesity and metabolic disorders are 
associated with adipocyte size and turnover 10 and indeed we found adipocyte hypertrophy in 
ScAT and PgAT in CoD-fed MT and WeD-fed mice in both sexes. The increased 
accumulation of lipids suggested that MT mice could have impairments in lipid metabolism, 
hence dyslipidaemia. Hyperlipidaemia is the most common form of dyslipidaemia, 
characterised by elevated levels of triglycerides, cholesterol and lipoproteins in the blood 117. 
In 12-week-old mice, all groups demonstrated a significant increase in basal triglycerides and 
cholesterol compared to CoD-fed WTs, except for WeD-fed female WTs. During CoD the 
hypertriglyceridemia appeared earlier in females than males. An opposite trend was found for 
the development of hypercholesterolemia. Noteworthy, the pattern of dyslipidaemia found in 
WeD-fed WT mice was very similar to the CoD-fed MT until the end of the study. Finally, 
the synergistic effect of combining genotype and diet resulted in the worst hyperlipidaemia 
levels. Similar results have been also described in patients with certain  polymorphisms in the 
Snap25 gene, treated with antipsychotic drugs for schizophrenia, where elevated serum 
triglycerides levels and body weight gain have been described 118,119. We have also analysed 
humoral factors such as leptin and ghrelin since it is known that their abnormal release is 
associated with obesity and metabolic dysfunctions 115. Measurements of basal serum leptin 
levels revealed that in CoD-fed MT females they were significantly higher than WTs. Again, 
the effect of both SNAP-25b-deficiency and diet resulted in the worst phenotype. Ghrelin was 
decreased in all experimental groups compared to CoD-fed WTs, in accordance with 
conditions associated to metabolic impairment 120,121.  
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4.1.4 SNAP-25b-deficiency induces liver dysfunction  
The increased levels of serum leptin led us to study leptin resistance in the liver, as it is a 
target tissue during metabolic disease 115. Independently of sex, the long isoform of the ObR, 
ObRb, was down-regulated compared to CoD-fed WTs in all experimental groups. 
Interestingly, the short isoform of the receptor, ObRa, was detectable only in MT mice, 
maybe as an attempt to compensate for decreased ObRb expression. We have also 
determined lipid accumulation in liver and found that SNAP-25b-deficiency was sufficient to 
turn the liver into a hepatic steatosis status, similarly to WeD-fed WT animals. When the 
mutation was combined with WeD the liver disease turned to severe fatty liver disease. The 
hypothalamus has a major role into hepatic lipid metabolism and storage via the autonomic 
nervous system and it is believed that increased sympathetic activity induces lipid 
accumulation in the liver 122,123. In our SNAP-25b-deficient mice it is plausible that the 
impaired neuroexocytosis from autonomic nerves causes liver steatosis. 
To summarise, in Paper I we have tested if a small genetic modification in the SNARE 
complex (i. e., replacing SNAP-25b with SNAP-25a), likely resulting in altered release of 
hormones, like insulin, could provoke metabolic syndrome in mice. Indeed, already at 12 
weeks of age, mice carrying this mutation developed symptoms of metabolic disease, which 
became full-blown when fed the WeD. It is tempting to hypothesise that also in humans such 
mutations, combined with an unhealthy diet and a sedentary life could be part of the 
triggering factors for the development of metabolic disease.    
4.2 PAPER II 
In Paper I, we have studied the metabolic consequences of the lack of SNAP-25b in vivo and 
found it correlated to an increased insulin secretion during GTT. In Paper II, we funnelled 
down to investigate the effect of SNAP-25b-deficiency on insulin secretion from beta cells 
and islet physiology, hypothesizing that this could contribute to development of the metabolic 
syndrome 8. We expected SNAP-25b-deficiency in beta cells to lead to a facilitated release, 
primarily affecting the dynamics of different pools of insulin granules 42,53. Indeed, we found 
an increased insulin secretion phenotype, however, this was instead associated with poorly 
controlled Ca2+ dynamics among beta cells in SNAP-25b-deficient mice. These results 
indicated additional functions of the SNAP-25 isoforms beyond their classical role in the 
SNARE complex mediating membrane fusion. Coordination of Ca2+ oscillations in beta cells 
is fundamental for a physiological release of insulin and disruptions of this mechanism can 
lead to development of insulin resistance and obesity 124. The experiments were run in 12-
week-old male and female, WT and MT mice on CoD. 
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4.2.1 SNAP-25b-deficiency increases insulin secretion and affects islet 
morphology 
Although SNAP-25b is the least abundant isoform in the endocrine beta cell 46,53, we found 
increased insulin secretion in islets isolated from MT mice compared to WTs when perifused 
with 11 mM glucose and 25 mM KCl. This secretion pattern was also found in vivo when the 
mice were challenged with a 15 min-long GTT. Serum insulin levels in MT mice were higher 
at all time points, although the blood glucose remained unchanged compared to the WTs. 
Interestingly, the WT females were found to have consistently lower serum insulin levels 
compared to WT males and therefore MT females demonstrated hyperinsulinemia and 
hyperglycaemia compared to their corresponding WT littermates. These results were also 
supported by the calculation of HOMAIR, an estimation of insulin resistance which indicated 
that WT females were more sensitive to insulin compared to WT males, probably due to 
different body composition. 
To investigate if the increased insulin secretion was attributed to altered islet morphology and 
cell distribution, we analysed pancreatic sections immunolabelled for insulin and glucagon as 
well as H&E labelled sections. First of all, we noticed the same characteristic spatial 
distribution of alpha and beta cells in SNAP-25b-deficient islets as in the WTs. More detailed 
analyses revealed that MT males had an increased number of insulin-positive cells per islet as 
well as larger islets compared to WT males, which could in part explain the increased insulin 
secretion. The number of alpha cells in islets was identical in WT and MT islets. Remarkably, 
islets from WT females contained more beta cells compared to WT males, although the 
individual beta cells were smaller in size, as determined by membrane capacitance 
measurements. WT females were found to have the highest number of islets among the 
groups. No signs of apoptosis were detected in beta cells in MT mice as compared to WTs. 
Taken together, the differences found between WT males and females is maybe attributed to 
the compensation of energy demands females encounter in case of pregnancy 125.  
4.2.2 SNAP-25b-deficiency does not influence Ca2+-sensitivity or rate of 
exocytosis 
As we hypothesised that the increased insulin secretion in MT islets was dependent on less 
stable SNARE complexes that could facilitate exocytosis, we performed experiments with 
slow photo-release of caged Ca2+ in beta cells with patch clamp. To do so we took advantage 
of the pancreatic tissue slice technique, where it is possible to get access to populations of 
beta cells resident in the islet core and beta cells are surrounded by their natural environment, 
the exocrine pancreas 90. Slow photo-release of caged Ca2+ produces a ramp-like increase in 
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[Ca2+]i up to a threshold value (Catr) that triggers exocytosis, measured as a biphasic increase 
in membrane capacitance 126. To our surprise, when [Ca2+]i raised no difference was found 
either in Ca2+ sensitivity, amplitude or rate of exocytosis between WT and MT beta cells. 
Therefore, the increased secretion found in vivo and in vitro could not only be dependent on 
the stability of SNARE complexes formed with either isoforms.  
4.2.3 SNAP-25b is necessary for accurate regulation of Ca2+ dynamics in 
beta cells 
We hypothesised that the different SNAP-25 isoforms might act differently on upstream 
targets involved in insulin exocytosis. It is known that SNAP-25, also in combination with 
syntaxin, binds to a number of proteins important for ion trafficking and electrical activity in 
excitable cells, such as VDCCs and K+ channels 54–56,127–129.  
We therefore explored if SNAP-25b-deficiency affected intracellular Ca2+ dynamics in beta 
cells using functional Ca2+ imaging on pancreatic tissue slices. When we stimulated the islets 
with 12 mM glucose, the initiation phase started with its characteristic progressive 
heterogeneous recruitment of beta cells 90 and beta cell activation time spanned from 1 to 6 
min in all experimental groups. Interestingly, in islets from MT mice a subgroup of beta cells 
responded earlier, which reflected an overall less regulated and faster glucose-induced Ca2+ 
response. When we removed high glucose, the beta cells deactivation started after 2-3 min 
and propagated within the islet with a high grade of heterogeneity from islet to islet, 
sometimes lasting even longer than 20 min. A detailed analysis revealed that in males, beta 
cells in MT islets experienced a deactivation process significantly longer than WTs. 
A consistent part of the Ca2+ imaging analysis was dedicated to the “active” stimulatory 
phase in beta cells which was reached after 7-15 min of 12 mM glucose exposure and is 
predominantly characterised by sustained oscillatory Ca2+ activity, superimposed on an 
elevated basal Ca2+ level 90. First of all, we calculated the mean frequency and duration of 
individual Ca2+ oscillations for all experimental groups and found no significant differences 
except for increased mean pulse duration in MT females compared to WTs. However, when 
we calculated the mean coactivity we disclosed a low grade of synchronicity between beta 
cells within MT islets compared to WTs in both males and females, indicating a weaker 
collective control of Ca2+ elevations. These characteristics in MT islets together with the 
morphological changes observed at least in males suggested lesions in the quality of beta cell-
to-cell interaction and hence possibly influencing hormonal secretion. We studied the 
functional connectivity profiles in all subgroups using analytical tools from the theory of the 
complex network 130. Previous studies on beta cell networks indicated that they form 
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heterogeneous, efficient and clustered architecture 131–134. When we calculated the 
modularity, we found that functional networks extracted from MT males were more 
segregated compared to WTs. The modular connectivity could be dependent on beta cell 
hyperplasia found in MT males coupled with looser connections between beta cells as the gap 
junction conductance, measured by patch clamp, tended to be decreased in MT compared to 
WT cells. Also, the spatial distribution of frequencies within the islet indicated a segregation 
of beta cell activity in MTs. During the last years, correct inter-beta-cell-connectivity within 
the islet has been described as fundamental for the generation of coordinated rhythmic insulin 
release and this complex network can be disrupted during the pathogenesis of T2D 99,101–
103,135. In our MT mice, we found increased glucose-induced insulin release associated with 
less synchronised Ca2+ oscillations, which is in line with previous results from other groups 
81,99,100. Although we have not focused our research on pulsatile insulin secretion, a trait 
impaired during the progression of T2D, this might be a possible effect behind the 
deregulated Ca2+ dynamics, leading to progressive insulin resistance. 
Altogether, the results in Paper II indicate that, although SNAP-25b is the minor isoform in 
beta cells, its function cannot be replaced by SNAP-25a. Islets lacking SNAP-25b were found 
to secrete high levels of insulin upon glucose stimulation and this was associated with 
derangement in islet morphology and less well controlled Ca2+ oscillations in beta cells. The 
lost regulation of beta cell activity behind the increased insulin secretion can, in a long term, 
provoke insulin resistance in peripheral tissues, hence contributing to the development of 
metabolic syndrome characterised in Paper I.  
4.3 PAPER III 
In Paper II we have shown that SNAP-25b-deficiency in islets results in a phenotype not 
entirely dependent on mechanisms downstream Ca2+ entry, suggesting other roles of the 
SNAP-25 isoforms “outside” the core SNARE complex. It has previously been demonstrated 
that SNAP-25b confers an increased thermostability to the complex compared to SNAP-25a 
51,52, possibly forming more hydrogen bonds between the proteins. However, during 
physiological conditions, differences in thermostability above 70 °C are not relevant, but the 
additional chemical bonds can change the tertiary structure of the four-alpha-helical bundle of 
the SNARE complex. Therefore, it is plausible that SNAP-25a and SNAP-25b might 
differently mediate interactions with binding partners. To investigate this hypothesis, we run 
immunoprecipitations of SNAP-25-containing complexes in the hippocampus from WT and 
MT mice. The hippocampus is one of the few brain areas where SNAP-25a is almost 
completely replaced by the SNAP-25b isoform in adulthood 43, thus we selected to work with 
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this region. We focused on interactions with the SNARE partners, syntaxin 1 and VAMP-2, 
as well as with proteins important for initiating or inhibiting membrane fusion events, such as 
Munc18-1 and the Gβγ subunits of the heterotrimeric G proteins, respectively 31,68,70,136 . 
First of all, we quantified the total protein expression levels in hippocampi from WT and MT 
mice and found no significant difference in SNAP-25, syntaxin 1, VAMP-2, Munc18-1 and 
Gβ1-4 proteins. We then continued by immunoprecipitating molecular complexes using 
SNAP-25 as bait. We could not detect any changes in the amount of the SNARE complex 
proteins, syntaxin 1 and VAMP-2, bound to either SNAP-25 isoform whereas an effect was 
detected for Munc18-1 and Gβγ. SNAP-25a was able to attract only half of the amount of 
Munc18-1 compared to SNAP-25b, maybe reflecting a decreased capability of SNAP-25a-
containing SNARE complexes to be in a “primed” state. Interestingly, two bands appeared to 
be immunoreactive to the Gβ1-4 antibody in both WT and MT hippocampi (several control 
experiments for testing the specificity of the antibody were carried out). The heavier band 
was more diffuse, suggesting the presence of possible post-transcriptional modifications of 
this protein, the lighter band appeared instead sharper and more defined, thus likely indicating 
a unique population of unmodified protein. It is known that in mouse hippocampus the 
majority of Gβ isoforms consists of the Gβ1, Gβ2 and Gβ4 137. To investigate which isoforms 
interacted with SNAP-25, we analysed the two bands by mass spectrometry and found Gβ2 
and Gβ1 in the heavier and lighter band, respectively. No detectable levels of Gβ4 were 
found to interact with SNAP-25 in hippocampus. Not much is known about the functions of 
the different Gβ isoforms in synaptic inhibition except that in rat superior cervical ganglion 
neurons Gβ1 and Gβ2 account for the majority of voltage-dependent inhibition of N-type 
Ca2+ channels 138. SNAP-25 interaction to the Gβγ is a relatively new and very interesting 
area of research since it appears to be implicated in transient transmitter-mediated presynaptic 
inhibition and induction of presynaptic long-term depression, important for memory and 
learning processes 72. The mechanism of action has been proposed to involve the vesicle-
associated protein synaptotagmin, which can approach the SNARE complex and initiate 
exocytosis upon appropriate Ca2+ concentrations, but when a GPCR is activated, the Gβγ 
subunit competes with synaptotagmin for binding to the SNARE complex, thus inhibiting 
fusion 71 (Figure 3). With our experimental approach, we found that SNAP-25a was able to 
attract a significantly lower amount of Gβ2 compared to SNAP-25b, maybe meaning its 
decreased efficiency in inhibiting exocytosis upon certain stimuli. Moreover, proximity 
ligation assays on hippocampal sections confirmed that the interaction of the SNAP-25 
isoforms and the Gβγ was of a direct nature.  
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To summarise, it is plausible that the SNAP-25 isoforms might provide different regulation of 
membrane fusion events, by modified interaction with other SNARE-binding proteins. This 
could in part explain learning and memory dysfunctions associated to the SNAP-25b-
deficient mice 52 as well as increased hormonal secretion from peripheral tissues (Paper I and 





Stimulus-dependent regulated membrane fusion is a complex physiological process that 
enables secretory cells, such as neurons and beta cells, to secrete neurotransmitters/hormones 
upon appropriate stimuli. SNAP-25, together with syntaxin 1 and VAMP-2, forms the core 
SNARE complex, implicated in the last steps of exocytosis fusing the vesicle/granule and cell 
plasma membranes. SNAP-25 exists as two developmentally regulated splicing variants, 
SNAP-25a and SNAP-25b, differing in only 9 out of 206 amino acids. Both SNAP-25 
proteins can form SNARE complexes but their different roles in membrane fusion are not 
much investigated.  
By using a SNAP-25b-deficient mouse model, this thesis has focused on studying the 
functions of the SNAP-25 isoforms in glucose and insulin homeostasis in vivo. Normally both 
isoforms participate in the SNARE complex and thus exocytosis, but when mice expressed 
only SNAP-25a, this resulted in development of metabolic syndrome in adulthood which was 
more exacerbated when combined with a high fat/high sucrose diet. Symptoms characteristic 
of metabolic disease included hyperinsulinemia, insulin resistance, hyperglycaemia, liver 
steatosis and adipocyte hypertrophy. SNAP-25b-deficiency resulted in increased insulin 
secretion, not merely dependent on mechanisms downstream the Ca2+ entry but instead 
associated to desynchronization of Ca2+ dynamics among beta cells. The disrupted beta cell 
networks, together with changes in the islet morphology in MTs contributed to the secretion 
phenotype. Moreover, we found different binding abilities of the SNAP-25 isoforms for 
proteins modulating membrane fusion, a result that needs to be further investigated.  
In conclusion, the correct function of the exocytosis machinery is important for health and 
insults to genes coding for its protein components can provoke metabolic syndrome. The 
SNAP-25 splicing variants play different roles in secretion, and as we experimentally proved 
they cannot be interchangeable, without impairing insulin secretion. In the future it would be 
of interest to characterise SNAP-25 isoforms levels in islets from other models of metabolic 
disease, as well as from T2D donors for clinical implications. Moreover, we propose the 
SNAP-25b-deficient mouse as a useful model for studies on development and progression of 
the metabolic syndrome and for testing therapeutic interventions.   
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